Abstract
Background
Cerebral vasospasm has become the most concerning complication in patients with aneurysmal subarachnoid hemorrhage (aSAH) seen in the neurosciences intensive care unit (NSICU). Hemodynamic augmentation is frequently used to treat cerebral ischemia from vasospasm. In the last 5 years, posterior reversible encephalopathy syndrome (PRES) has been reported in three single case reports as a complication of hemodynamic augmentation. We describe an additional three patients seen in our institution.
Methods
Description of clinical course of three patients with a secured aneurysm treated with hemodynamic augmentation for cerebral vasospasm.
Results
We identified three patients (two female and one male), ranged in age from 62 to 70 years who developed PRES after treatment with induced or permissive arterial hypertension. During their NSICU stay, case 1 had worsening headache and confusion, case 2 and 3 had a decline in level of consciousness. Neuroimaging was compatible with vasogenic edema characteristic of PRES. Arterial blood pressure was reduced with a complete clinical and imaging resolution of PRES.
Conclusions
PRES can be a cause of deterioration in patients with aSAH treated with hemodynamic augmentation. PRES should be differentiated from evolving infarctions due to cerebral vasospasm. Clinical manifestations and neuroimaging findings are reversible after gradual normalization of blood pressure.
References
Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.
Fugate J, Claassen D, Cloft H, Kallmes D, Kozak O, Rabinstein A. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85:427–32.
Lee V, Wijdicks E, Manno E, Rabinstein A. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205–10.
Bederson J, Connolly E, Batjer H, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.
Kassell N, Peerless S, Durward Q, Beck D, Drake C, Adams H. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982;11:337–43.
Rabinstein A, Lanzino G, Wijdicks E. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarchnoid hemorrhage. Lancet Neurol. 2010;9:504–19.
Sanelli P, Jacobs M, Ougorets I, Mifsud M. Posterior reversible encephalopathy syndrome on computed tomography perfusion in a patient on “triple H” therapy. Neurocrit Care. 2005;3:46–50.
Wartenberg K, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging. 2006;16:170–5.
Jang H, Lee H. Posterior reversible leukoencephalopathy due to “triple H” therapy. J Clin Neurosci. 2010;17:1059–61.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giraldo, E.A., Fugate, J.E., Rabinstein, A.A. et al. Posterior Reversible Encephalopathy Syndrome Associated with Hemodynamic Augmentation in Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 14, 427–432 (2011). https://doi.org/10.1007/s12028-011-9515-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-011-9515-x